00019606-199812000-00006ArticleDiagnostic Molecular PathologyDiagnostic Molecular Pathology© 1998 Lippincott Williams & Wilkins, Inc.7December 1998
p 324–330Uterine Cervical Dysplasia and CancerIdentification of C-myc Status by Quantitative Polymerase Chain ReactionOriginal Article: PDF OnlyAoyama, Chisa M.D.; Peters, Julius Ph.D.; Senadheera, Shantha M.s.; Liu, Paul M.D., Ph.D.; Shimada, Hiroyuki M.D., Ph.D.Department of Pathology (C.A., P.L.), Olive View-UCLA Medical Center, Sylmar; and the Department of Pathology (J.P., S.S., H.S.), Childrens Hospital Los Angeles, Los Angeles, California, U.S.A.AbstractThe c-myc oncogene status was determined in patients with nondysplasia (ND; 9 patients), low-grade squamous intraepithelial lesion (LGSIL; 12 patients), high-grade squamous intraepithelial lesion (HGSIL; 21 patients) and invasive squamous cell carcinoma (ISCC; 20 patients) of uterine cervix using fluorescent quantitative polymerase chain reaction (PCR). In the same paraffin-embedded specimens, other potential risk factors were also screened: human papillomavirus (HPV) infection, Ha-ras codon 12 mutation, DNA aneuploidy. Gene amplification, identified as c-myc copy numbers greater than the mean value +2 SD of patients with ND, was seen in 44|X% patients with LGSIL, 76|X% patients with HGSIL, and 67|X% patients with ISCC. These data indicate that c-myc amplification is one of the critical early events in the progression of uterine cervical lesions. HPV infection of various subtypes was identified in 0|X% patients with ND, 55|X% patients with LGSIL, 95|X% patients with HGSIL, and 84|X% patients with ISCC. No codon 12 mutation of the Ha-ras gene was found in this series. Aneuploid DNA pattern was seen in 0|X% patients with ND, 58|X% patients with LGSIL, 90|X% patients with HGSIL, and 80|X% patients with ISCC. There was a significant correlation between HPV infection and DNA aneuploidy. However, no relationship was seen between c-myc status and other factors in this series. Patients with HGSIL and ISCC almost always (95|X%) had multiple risk factors, whereas more than half of the patients with LGSIL had no or only one risk factor (P = 0. 0001)Uterine cervical dysplasia; Cervical cancer; c-myc; Human papillomavirus; Ha-ras; DNA aneuploidy; Quantitative polymerase chain reaction.
Uterine Cervical Dysplasia and Cancer: Identification of C-<em xmlns:mrws="http://webservices.ovid.com/mrws/1.0">myc</em> Status by Quantitative Polymerase Chain ReactionAoyama Chisa M.D.; Peters, Julius Ph.D.; Senadheera, Shantha M.s.; Liu, Paul M.D., Ph.D.; Shimada, Hiroyuki M.D., Ph.D.Original Article: PDF OnlyOriginal Article: PDF Only67p 324-330